Gujarat Kidney & Superspeciality Reports Q2'27 IPO Funds Utilization and Approved Object Variations
Gujarat Kidney and Super Speciality Ltd · Others (Uncategorized) · 05 Nov 2026, 1:44 am
Gujarat Kidney & Superspeciality Reports Q2'27 IPO Funds Utilization and Approved Object Variations Gujarat Kidney and Superspeciality Limited reported its IPO proceeds utilization for the quarter ended 30th Sep'26, following its ₹250.80 Cr public issue raised on 24th Dec'25. Shareholders approved object variations via Postal Ballot on 22nd Aug'26, reallocating Vadodara capex funds toward broader healthcare expansion (₹17.92 Cr) and acquiring a 51% stake in Blue Tree Clinics LLC, Dubai (₹7.23 Cr), alongside repurposing robotics capex (₹6.83 Cr) for dialysis services. As of 1st Oct'26, unutilized IPO proceeds stand at ₹18.34 Cr.
Original exchange filing (PDF)
More announcements from Gujarat Kidney and Super Speciality Ltd
- Transcript of Earning Call conducted on 05/11/2026 · 11 Nov 2026
- Audio recording of earning call · 05 Nov 2026
- Revised presentation Uploaded for today''s Earning Con-Call. · 05 Nov 2026
- Investor Presentation for scheduled Conference Call on November 05, 2026 · 05 Nov 2026
- Monitoring Report for the Quarter ended September 30, 2026 · 05 Nov 2026
- Unaudited Standalone and Consolidated Financial Results for the Quarter ended September 30, 2026 · 05 Nov 2026
- Gujarat Kidney And Super Speciality Limited has submitted to the Exchange, the unaudited Standalone and Consolidated financial results for the period ended September 30, 2026. · 05 Nov 2026
- Earning Con-call · 05 Nov 2026
